SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is trending as community members rally around the OG meme, Rage Guy, aiming to revive early meme culture within the crypto space. The community emphasizes its strong base and organic growth, shunning traditional KOL influence. Discussions revolve around community spirit and a shared belief in the power of memes, with many expressing bullish sentiment.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Recent community discussions surrounding Compound ($COMP) are focused on concerns about the Compound Foundation's financial sustainability, potential governance issues, and comparisons to other projects in the Real World Asset (RWA) space. Some investors are expressing worry about a possible deficit and its impact on the protocol's future, while others remain optimistic about Compound's role in the evolving crypto landscape. Bullish investors point to the formation of the Compound Foundation and institutional interest as reasons for optimism.

“Hmmm” is a community meme token on the Solana network, launched on July 22, 2024, through Pumpfun. It’s a derivative of Pepe the Frog but has evolved into its own distinct meme with a unique identity. The token embraces the humor and intrigue of internet culture, playing on the idea of curiosity and speculation. “Hmmm” captures a playful approach to the world of meme tokens, designed to engage a community driven by fun and the whimsical side of crypto. Hmmm, maybe this’ll send.

hmmm

HMMM crypto is trending, with community members highlighting a potential breakout and early launch. Conversation is centered around the token's connection to Phantom Wallet, with some suggesting institutions are accumulating the crypto. Skepticism exists, with some users warning of a potential pullback.

Clanker is an autonomous agent for deploying tokens. Currently, users may request clanker to deploy an ERC-20 token on Base by tagging it @clanker on Farcaster.

tokenbot

Clanker Crypto is trending as users discuss issues with trading the token on Coinbase, including order filling and potential frozen markets. Despite these concerns, the community is also highlighting the token's limited supply and potential for significant price movement, with some anticipating a breakout and others pointing to bullish technical indicators. Some users believe it could be related to the Base App integration.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is trending as traders discuss its low market cap and potential for significant upward movement, with some eyeing a potential Binance listing as a major catalyst. Community members are actively speculating on entry points and anticipating a breakout, citing its limited supply and previous highs as reasons for optimism. Recent integration with Aleph Zero is also being highlighted.

Definitive is an onchain trading platform democratizing advanced trading tools for the masses. Trade any token on any chain with advanced trade order types including Market, Limit Buy/Sell, Stop Loss and TWAP orders.  Route your trade instantly across 100+ DEXs and liquidity pools to get the best prices on every trade. Definitive is built by former Coinbase Institutional trading alumni and active DeFi experts.

Definitive

Definitive (EDGE) is trending as the community discusses its potential for significant gains, drawing comparisons to AERO's early success and highlighting its low market cap. Bullish sentiment is fueled by its strong performance and anticipation of further price increases, with some speculating about a potential Binance listing. The platform's unique features, such as lower trading fees and cross-chain swaps, are also driving interest and user adoption.

Chevron Corp. engages in the provision of administrative, financial management, and technology support for energy and chemical operations. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron ($CVX) is trending due to discussions around potential impacts from geopolitical tensions in the Middle East, specifically related to Iran and the Strait of Hormuz, and production impacts to key assets like the Leviathan field. Community members are weighing the potential for supply disruptions and the impact on oil prices, while also discussing Chevron's strategic moves in areas like LNG and lithium production. Some are analyzing Chevron's valuation, dividend yield, and upcoming earnings.

SSgA Active Trust - The Energy Select Sector SPDR Fund

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund ($XLE) is trending amid rising geopolitical tensions, particularly concerns around potential disruptions in the Strait of Hormuz, which could impact global oil supply. Community members are actively discussing potential price targets, with some anticipating a breakout and others expressing skepticism, noting past volatility and OPEC's influence. Accumulation strategies and potential short-term gains are also being debated, as well as the impact of new tariffs.

Nucor Corp. engages in the manufacture of steel products, and ferrous and non-ferrous materials. It operates through the following segments: Steel Mills, Steel Products, and Raw Materials. The Steel Mills segment consists of producing sheet, plate, structural, and bar steel. The Steel Products segment includes steel joists and joist girders, deck, fabricated concrete reinforcing, cold finished, fasteners, metal building systems, grating, tubular, piling products businesses, and wire mesh. The Raw Materials segment consists of direct reduced iron, and ferrous and nonferrous metals. The company was founded by Ransom E. Olds in 1905 and is headquartered in Charlotte, NC.

Nucor Corp.

Nucor ($NUE) is trending as investors anticipate its upcoming Q3 earnings report, amidst pressure from lower segment earnings. Community discussion revolves around whether stable steel prices can offset these challenges and if Nucor can deliver an earnings beat, given a projected revenue increase but a negative Earnings ESP. The stock is also influenced by broader market dynamics, including competitor performance and speculation around potential infrastructure projects and tariff impacts under a new administration.

About Mistery On Cro $MERY was born with the idea of being a meme coin on Cronos chain during the exploding 2024 meme coin season. The founder is David Bui, a well-known and seasoned #crofam $CRO investor on Cryptocom products and a big -well respected- personality on X. David minted “Mistery On CRO” on Cronos blockchain with the purpose of making this chain much better, more popular and specially more fun, but aside from serving as a mere “meme”, $MERY has the ultimate goal of also being a utility token that the founder and the team behind will push to bring many benefits to loyal hodlers. Launched in 27/3/2024 at Sydney, Australia, local time 21h00, the 690,000 $CRO presale sold out within 2 hours. The founder burned the LP to a dead wallet and the contract ownership was renounced. $MERY during its first week of launch got instant traction from the OG #crofam community who jumped in and secured bags. We are now a thriving community that will help nurturing and growing the project by sharing with more and more Web3 users.

Mistery

Mistery ($MERY) is trending alongside Cronos ($CRO), with many noting their correlated movements and anticipating further gains. Community members highlight a new Telegram game and growing ecosystem, while also pointing to significant accumulation by a major exchange. Some users speculate about potential integrations with emerging platforms.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Adverum Biotechnologies Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adverum Biotechnologies, Inc. - ADVM

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Adverum Biotechnologies, Inc. (NasdaqCM: ADVM...

NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?

Novo Nordisk faces headwinds and leadership shifts, while Structure Therapeutics eyes pivotal obesity-drug data later this year.

Trade Truce Hope: How US-China Talks Could Boost Healthcare ETFs

Hopes of a U.S.-China trade truce are lifting sentiment for healthcare ETFs like XLV, IYH, and VHT, which could gain from easing tariffs and lower costs. 

Incyte Gears Up to Report Q3 Earnings: Is a Beat in the Cards?

INCY eyes strong Q3 performance with Jakafi, Opzelura, and new launches like Niktimvo driving revenues.

Here's How Eli Lilly's Oncology Drugs Are Poised Ahead of Q3 Earnings

LLY's oncology portfolio, led by Verzenio, is set for double-digit growth as investors eye Q3 results beyond its obesity drugs.

<ul class="summary-bullets"><li>Under the deal, Lilly will commence a tender offer to acquire all of the outstanding shares of Adverum common stock at a per-share price of $3.56, payable in cash at closing, plus milestone payments of up to $8.91 per contingent value right.&nbsp;</li><li>The transaction is expected to close in the fourth quarter of 2025, subject to satisfaction of the closing conditions. &nbsp;</li></ul>Eli Lilly and Company (LLY) said on Friday that it has entered into a definitive agreement to acquire Adverum Biotechnologies, Inc. (ADVM) for a total potential per share consideration of up to $12.47.Under the <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/lilly-to-acquire-adverum-biotechnologies-302593482.html">deal</a>, Lilly will commence a tender offer to acquire all of the outstanding shares of Adverum common stock at a per-share price of $3.56, payable in cash at closing, plus milestone payments of up to $8.91 per contingent value right. The upfront cash payment, however, represents a discount of about 15% from the stock’s closing price on Thursday.The transaction is expected to close in the fourth quarter of 2025, subject to satisfaction of the closing conditions.<h2 class="st-heading-2">Board’s View</h2>Adverum said the transaction was unanimously approved by its board of directors following an evaluation of strategic alternatives and discussions with potential partners and buyers. It added that the board believes the agreement with Lilly is in Adverum's and its stockholders' best interests.The acquisition includes Adverum’s lead product candidate Ixo-vec, a late-stage gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose. The milestone payments in the deal are associated with the development of the gene therapy, including U.S. approval.<h2 class="st-heading-2">Fund Arrangements</h2>Adverum has also entered into a Promissory Note with Lilly in conjunction with the transaction that enables it to receive a loan of up to $65 million from Lilly, drawable in four installments, subject to specified conditions. The loan can be used to support ongoing Ixo-vec clinical trials and registrational development activities prior to the anticipated closing of the transaction, it said.Shares of ADVM soared 3% on Friday morning at the time of writing. On Stocktwits, retail sentiment around ADVM soared from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘extremely low’ to ‘high’ levels.<a href="https://stocktwits.com/symbol/ADVM">ADVM stock</a> is down by 7% this year and by about 46% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/gm-reportedly-lays-off-over-200-employees-days-after-raising-2025-earnings-guidance/cLGJFcKR3tb">GM Reportedly Lays Off Over 200 Employees Days After Raising 2025 Earnings Guidance</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The entrance to the Eli Lilly factory in Kinsale, Co Cork, where weight loss drug Mounjaro is made. Picture date: Sunday May 18, 2025.

Eli Lilly To Acquire Adverum Biotechnologies

Under the deal, Lilly will commence a tender offer to acquire all of the outstanding shares of Adverum common stock at a per-share price of $3.56, payable in cash at closing, plus milestone payments of up to $8.91 per contingent value right. 

Equity

Lilly to Acquire Adverum Biotechnologies

Lilly to Acquire Adverum Biotechnologies Lilly to Acquire Adverum Biotechnologies PR Newswire INDIANAPOLIS and REDWOOD CITY, Calif., Oct. 24, 2025 Adverum's lead program, Ixo-vec, is a Phase 3 gene...

Lilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial

Lilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial Lilly's baricitinib delivered near-complete...

Lilly's EBGLYSS (lebrikizumab-lbkz) delivered durable disease control when administered once every eight weeks in patients with moderate-to-severe atopic dermatitis

Lilly's EBGLYSS (lebrikizumab-lbkz) delivered durable disease control when administered once every eight weeks in patients with moderate-to-severe atopic dermatitis Lilly's EBGLYSS...

Lilly Up 10% in a Month: Should You Buy, Sell or Hold the Stock?

Lilly stock climbs nearly 10% in a month amid a broader recovery in the drug and biotech sector.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$5.92	--	--	N/A
Q2 '25	$5.60	$6.31	12.70%	BEAT
Q1 '25	$3.26	$3.34	2.51%	BEAT
Q4 '24	$5.01	$5.32	6.15%	BEAT
Q3 '24	$1.45	$1.18	-18.79%	MISSED

LLY
Lilly(Eli) & Co

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest LLY News

LLYLilly(Eli) & Co